Where is TheraVet located?

TheraVet is headquartered in Charleroi, Belgium.

Who is the current CEO of TheraVet?

Enrico Bastianelli of TheraVet.

How many employees does TheraVet have?

As of Aug 31, 2026, the latest employee count at TheraVet is 1.

What is the annual revenue of TheraVet?

Annual revenue of TheraVet is less than €1M as on Dec 31, 2023

Where does TheraVet rank among its competitors?

TheraVet ranks 19th amongst 151 active competitors, of which 12 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Unibio, which secured an undisclosed amount in Mar, 2023.

Who are the top competitors of TheraVet?

TheraVet's top competitors include Maev, Blackmores and Bioage. Among them, Unibio secured the most recent funding round in March, 2023.

TheraVet - 2026 Company Profile, Team, Funding, Competitors & Financials

TheraVet is a public company based in Charleroi (Belgium), founded in 2017 by Enrico Bastianelli. It operates as a Developer of drugs for the treatment of osteoarticular problems. The company has 151 active competitors, including 12 funded and 13 that have exited. Its top competitors include companies like Maev, Blackmores and Bioage.

Company Details

Thera is a developer of drugs for the treatment of osteoarticular problems. It has developed effective treatments for orthopedic and osteoarticular indications. The products BIOCERA-VET is a line of injectable self-hardening phosphocalcic bone void fillers with enhanced osteointegration, osteoinduction, and bone remodeling properties. Another one is VISCO-VET that is a versatile line of enhanced visco-supplements with anti-inflammatory and pro-regenerative properties. BIOCERA-VET helps in bone surgeries, osteosarcoma, bone cytes, and others. VISCO-VET helps in osteoarthritis, cranial cruciate ligament deficiency, tendon and ligament injuries, and many more.

Website: www.thera.vet/
Email ID: *****@thera.vet

Key Metrics

Founded Year

2017

Location

Charleroi, Belgium

Stage

Public

Investors

Theodorus & 1 more

Ranked

19^th among 151 active competitors

Annual Revenue

€0 - €1M as on Dec 31, 2023

Employee Count

1 as on Aug 31, 2026

Similar Companies

Maev & 154 more

Exit Details

Public

View TheraVet's full profile

TheraVet is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Theravet Sa CIN: 0684.906.013 , Belgium, Active	Nov 21, 2017	€0 - €1M (As on Dec 31, 2023)	13 (As on Dec 31, 2021)	-

TheraVet got listed on Jun 17, 2021.

Click here to take a look at TheraVet's IPO in detail

TheraVet is a funded company. TheraVet has 2 institutional investors.

View details of TheraVet's funding rounds and investors

The founders of TheraVet is Enrico Bastianelli.

Here are the details of TheraVet's key team members:

Enrico Bastianelli: Founder & CEO of TheraVet.

View details of TheraVet's Founder profiles and Board Members

TheraVet's employee count trend

TheraVet has 1 employees as of Aug 26. Here is TheraVet's employee count trend over the years:

Uncover TheraVet's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TheraVet include Maev, Blackmores and Bioage. Here is the list of Top 10 competitors of TheraVet, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Maev 2018, New York City (United States), Series A	Provider of internet-first brand for nutrition and wellness product for dogs	$19M	VMG Partners, Springdale Ventures & 8 others	59/100
2nd	Blackmores 1932, Sydney (Australia), Acquired	Health products for humans and animals, including vitamins, herbal and mineral nutritional supplements.	-	Ethical Advisers Funds Management	51/100
3rd	Bioage 2001, Niagara Falls (United States), Series B	Manufacturer of algal extracts nutritional products	$37M	Felicis Ventures, AME Cloud Ventures & 5 others	50/100
4th	Lintbells 2006, Hitchin (United Kingdom), Acquired	Manufactures a range of health supplements for humans and animals	-	Inflexion, Origin Capital & 7 others	49/100
5th	YuMOVE 2006, Hitchin (United Kingdom), Acquired	Veterinary joint supplements for dogs, cats, and horses	-	-	48/100
6th	Unibio 2001, Odense (Denmark), Series D	Pioneering planet-friendly protein production through advanced fermentation for animal and human nutrition	$30M	West Hill Capital, Saudi Industrial Investment Group ... & 3 others	48/100
7th	FoodScience 1972, Chittenden (United States), Acquired	Developer of nutritional supplements	-	-	47/100
8th	Rooted Owl 2022, New York City (United States), Unfunded	Provider of veterinarian-formulated pet supplements to support pet health and wellness	-	-	43/100
9th	Pellucid Lifesciences 2013, Ahmedabad (India), Unfunded	Developer of probiotics for human and animal health	-	-	42/100
10th	Ayurvet 1992, Delhi (India), Acquired	Manufacturer of animal healthcare products for livestock, poultry, and companion animals	-	Vic Enterprises, Gyan Enterprise & 5 others	39/100
19th	TheraVet 2017, Charleroi (Belgium), Public	Developer of drugs for the treatment of osteoarticular problems	-	Theodorus, Investsud	34/100